Doctor Anywhere Ran The Digital Playbook Backwards
It began in 2017 as a Singapore app that put a licensed doctor on your screen in minutes. Then it did the thing software companies are told never to do: it bought clinics, a listed specialist group, and a floor of imaging machines on Orchard Road. Roughly 3 million users later, that choice looks less like a detour and more like the whole strategy.
In 2016, a Singaporean private equity investor named Lim Wai Mun spent a weekend handing out meals to elderly residents in public housing blocks. He was there for the food run. What he came away with was a different observation entirely: the people opening those doors were not primarily short of dinner. They were short of doctors. Some had not been examined in years, not because care did not exist but because a flight of stairs, a bus ride and a two-hour queue stood between them and it.
He had spent his career nowhere near medicine. A mechanical engineering degree from the National University of Singapore, three years investing in Asian real estate at Standard Chartered Private Equity, then Temasek Holdings, where he helped conceptualise and stand up Pavilion Energy, a liquefied natural gas venture. Nothing about that resume suggests primary care. In 2017 he left anyway and founded Doctor Anywhere.
The first version was the obvious one: an app that connects a patient by video to a Singapore-registered doctor, with medication couriered afterwards. Dozens of companies across Southeast Asia launched something similar in the same window. What separates Doctor Anywhere from most of them is what happened next, and it is the opposite of what a software founder is supposed to do.
The company that walked backwards
Digital health in 2019 and 2020 had an orthodoxy. Stay asset-light. Own the interface, rent everything behind it. Let hospitals carry the buildings, the machines and the payroll while you take a margin on the routing.
Doctor Anywhere concluded this was wrong, or at least insufficient. Lim has explained the pivot plainly: the company found that "physical presence is very important in order to build trust with users." So it started acquiring the heavy things. GP clinics under the DA Clinic banner. In 2021, the Thai telemedicine platform Doctor Raksa. In December 2022, and this is the one people remember, an SGX-listed specialist medical group called Asian Healthcare Specialists - orthopaedics, dermatology, gastroenterology, ophthalmology, urology, ENT, anaesthesia, rehabilitation. In 2023, DA Orchard MedSuites, roughly 12,000 square feet of health screening and radiology, X-ray through MRI and CT, on a road otherwise known for luxury malls.
"We've successfully built a regional digital healthcare ecosystem, delivering accessible and convenient healthcare services through digital innovation."
Lim Wai Mun, Founder & CEO, December 2023
Harvard Business Publishing eventually wrote a teaching case on the company. Its subtitle is "from online to offline" - four words that reverse the direction of nearly every other business school case written in the last fifteen years.
The stack Doctor Anywhere assembled
One patient, five possible depths of care - all inside the same network.
What it actually sells, and to whom
Doctor Anywhere has three customers who want three different things from the same appointment, which is unusual and useful.
Consumers
Pay per teleconsult, clinic visit, screening package, house call or marketplace order. Value: speed, and not losing a workday.
Employers
Buy corporate health plans, pre-employment and annual screening, and Soda by DA, the flexible benefits platform. Value: coverage and administration that does not require an HR department.
Insurers & HMOs
Contract DA as a covered care channel, so members consult at little or no out-of-pocket cost. Value: cheaper front-line care and fewer avoidable claims.
The product list underneath is longer than most people expect from a company they think of as "the doctor app." Alongside the virtual clinic sit vaccinations and childhood immunisation, chronic disease management, mental wellness teleconsults with psychologists and counsellors, nutrition and fitness programmes, and a set of frankly practical categories the company treats without ceremony - birth control, skin health, weight management, hair loss, erectile dysfunction, smoking cessation, travel health. There is a marketplace inside the app for supplements, OTC medication and devices, delivered.
That last cluster deserves a note. A meaningful share of telemedicine's real-world value is not emergency medicine. It is that some conversations are easier to have with a screen than with a receptionist and a waiting room of neighbours. Doctor Anywhere built dedicated pathways for exactly those conversations, which is a product decision disguised as a menu.
The money, and who put it in
Roughly US$176 million has gone into the company since 2017. The composition of the cap table is more interesting than the total. Asia Partners led the S$88 million Series C in August 2021. Novo Holdings - the investment arm behind one of the world's largest diabetes care franchises - came in then and led again later. Philips, a medical device manufacturer, invested. So did IHH Healthcare, one of Asia's largest hospital operators. EDBI, the Singapore state-linked investor, was already in. Square Peg, Kamet Capital, Pavilion Capital and OSK-SBI fill out the rest.
Funding history, US$ millions
Seed through Series C1. Figures as reported; earlier rounds approximate.
When a hospital group, a device manufacturer, a life sciences fund and a sovereign-linked investor all appear on the same line, they are not agreeing about a pitch deck. They are each buying a different piece of distribution. Reported revenue was about S$81.7 million for FY2023.
Where it sits in a crowded region
Southeast Asia has something on the order of 461 telemedicine startups, of which roughly 75 have raised outside money and a much smaller number have reached Series A and beyond. In Singapore alone Doctor Anywhere has competed against at least ten other providers. Halodoc and Alodokter dominate mindshare in Indonesia. DoctorOnCall and Doc2Us in Malaysia. WhiteCoat, Speedoc, MyDoc and Doctor World locally. Grab has taken runs at health. The real incumbent, though, is not any of them - it is the neighbourhood GP chain and the hospital outpatient department that people have used their whole lives.
| Layer of care | Typical pure-play telehealth | Doctor Anywhere |
|---|---|---|
| Video consultation | Owned | Owned |
| Medication fulfilment | Partnered | Owned / integrated |
| GP clinic visit | Referred out | Owned (DA Clinic) |
| Screening & imaging | Referred out | Owned (DA MedSuites) |
| Specialist consultation | Referred out | Owned (AHS) |
| Home visits | Rarely offered | Owned (House Calls) |
| Employer benefits admin | Occasionally | Owned (Soda by DA) |
The strategic logic is not complicated once you see it laid out. A teleconsultation is a low-value transaction. A knee replacement, a cancer screening pathway or a decade of managed hypertension is not. Every referral out of the network is a handoff of the expensive part. Doctor Anywhere spent five years and most of its capital making sure fewer of those handoffs happen.
"Cultivating a balance between technology and human touch."
Lim Wai Mun on differentiation, TechCrunch, 2021
That line reads like standard corporate copy until you notice the company spent nine figures backing it with leases, machines and salaried clinicians.
The parts that did not work
A profile that only lists acquisitions is a brochure. Two things went the other way. In December 2024 the company cut about 45 roles, roughly 8.1% of regional headcount, concentrated in its technology teams; it stated no doctors or health professionals were affected, and framed it as adapting to economic conditions and securing long-term sustainability. Then in July 2025 it wound down operations in Vietnam - a market it had entered with a distribution partnership reaching millions of mobile wallet users - to concentrate on its remaining markets. Vietnam's pure-play digital health sector had a difficult stretch generally; Doctor Anywhere was not the only company to leave.
Both decisions point the same way. The expensive, physical, regulated half of the business was protected. The lighter half absorbed the cut. Whether that is the right call is arguable. What it is not is accidental.
Expertise, and the regulatory grind
The unglamorous competence here is regulatory. Running care in Singapore, Malaysia, Thailand, Indonesia and the Philippines means five licensing regimes, five prescribing rulebooks, five sets of data protection obligations and five insurance markets that do not resemble each other. There is no software leverage on that work. It is done by people, market by market, and it is the reason regional healthtech is harder than regional e-commerce.
In Singapore, DA Clinics participate in Healthier SG, the national programme that asks residents to enrol with a regular family doctor and shift the system toward prevention, as well as the CHAS subsidy scheme. A venture-backed company operating inside national health policy is a specific kind of arrangement, and it is a durable one. Governments do not switch primary care providers casually.
Nine years, compressed
From a food delivery round to a five-market care network.
What you can take from this
Three things travel outside healthcare.
- Trust has a physical component. The company's own conclusion, arrived at through data rather than sentiment, was that people commit more readily to a health provider they could theoretically walk into. That is a general finding about any product handling something a customer is afraid of.
- Own the step after your product. Whoever handles the next thing the customer needs tends to inherit the relationship and the larger invoice. Doctor Anywhere's entire acquisition history is one long version of this sentence.
- Multiple payers change the maths. The same consultation can be sold to a patient, an employer and an insurer, because each values a different outcome. Most companies stop looking after they find the first buyer.
Nine years on from a food delivery round, Doctor Anywhere describes what it built as "Hospital Anywhere" - a hospital taken apart and redistributed across a phone, a shopfront GP practice, a screening floor and a doctor knocking on a front door. The seniors Lim met in 2016 were not going to reach a hospital. So the hospital, in pieces, went to them.
Official & Social
- doctoranywhere.com
- About Doctor Anywhere
- X / Twitter
- TikTok
- iOS app
- Company blog
- Help centre
Products & Services
Reporting & Analysis
- TechCrunch: S$88M Series C
- DealStreetAsia: AHS acquisition
- e27: acquisition + US$38.8M
- MobiHealthNews: Series C
- Digital News Asia: Series C1
- HRD: 2024 restructuring
- DealStreetAsia: Vietnam exit
- Tatler Asia: founder interview
- Singapore Global Network profile
- HBP case: online to offline